Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Righttothetopon Jun 02, 2021 9:37am
189 Views
Post# 33309885

RE:RE:RE:RE:RE:RE:filing...what is the deal?

RE:RE:RE:RE:RE:RE:filing...what is the deal?Apart from a minor increase lately, there is nothing to suggest than anything is cooking....and that may or may not be a problem.

Chief among the issues is that this ship has no captain at the moment, and they need a Kirk or Picard not some Starfleet graduate.....so we wait until they do the most exhaustive CEO search in modern times for a weed sector startup.....I sure do hope it's taking this long because they're leaving no stone unturned rather than not having the right applicants.

But in the end, LABS needs one thing immediately, execution on all of these global deals they penned over the last few years.  If Stada is sitting on their inventory and can't push it with all of their EU might, then we could be in trouble....but if they can't keep these products stocked; we're in good shape.  Won't know for sure until a Q or two.  But this will be the metric and the only one that matters.

One board member (and I'd go so far to say the one who knows capital markets best) decided to invest a small fortune (in terms of us working plebs) so maybe there is something....a slow cold toffee recovery isn't what this biz needs.....we need a bit quicker than that.....
<< Previous
Bullboard Posts
Next >>